(S)-CPW 399

Discontinued Product

1543 has been discontinued.

View all AMPA Receptors products.
说明: Subtype-selective weakly desensitizing AMPA agonist
化学名: (S)-α-Amino-2,3,4,5,6,7-hexahydro-2,4-dioxo-1H-cyclopentapyrimidine-1-propanoic acid
纯度: ≥98% (HPLC)
说明书
引用文献
评论
文献 (4)

生物活性 for (S)-CPW 399

Novel subtype-selective and weakly desensitizing AMPA receptor partial agonist (Ki values are 44, 109, 223, 1890 and 2090 nM at GluK1, GluA1, GluA2, GluA3 and GluA4 receptors respectively). Exhibits potent agonist activity at GluA1 and GluA2 subunit-containing AMPA receptors (EC50 values are 24.9 and 13.9 μM respectively) and is excitotoxic in vitro.

Please refer to IUPHAR Guide to Pharmacology for the most recent naming conventions.

技术数据 for (S)-CPW 399

分子量 239.23
公式 C10H13N3O4
储存 Desiccate at -20°C
纯度 ≥98% (HPLC)
CAS Number 389888-02-2
PubChem ID 657004
InChI Key VSGUEKZRMJVQOH-LURJTMIESA-N
Smiles O=C1NC(C2=C(CCC2)N1C[C@H](N)C(O)=O)=O

上方提供的技术数据仅供参考。批次相关数据请参见分析证书。

Tocris products are intended for laboratory research use only, unless stated otherwise.

产品说明书 for (S)-CPW 399

分析证书/产品说明书
选择另一批次:

按产品操作查看相关产品

查看全部 AMPA Receptor Agonists

关键词: (S)-CPW 399, (S)-CPW 399 supplier, Subtype-selective, weakly, desensitizing, AMPA, agonists, Glutamate, Receptors, iGlur, Ionotropic, (S)-CPW399, 1543, Tocris Bioscience

篇 (S)-CPW 399 的引用文献

引用文献是使用了 Tocris 产品的出版物。

目前没有 (S)-CPW 399 的引用文献。

(S)-CPW 399 的评论

目前没有该产品的评论。 Be the first to review (S)-CPW 399 and earn rewards!

Have you used (S)-CPW 399?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

该领域的文献

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*请注意,Tocris 仅会向正规科研企业/机构地址发送文献。


Addiction Poster

Addiction Poster

The key feature of drug addiction is the inability to stop using a drug despite clear evidence of harm. This poster describes the brain circuits associated with addiction, and provides an overview of the main classes of addictive drugs and the neurotransmitter systems that they target.

Alzheimer's Disease Poster

Alzheimer's Disease Poster

Alzheimer's disease (AD) is a debilitating and progressive neurodegenerative disease and the most common cause of dementia, affecting approximately 30% of individuals aged over 85 years. This poster summarizes the cellular and molecular mechanisms of AD.

Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.

Parkinson's Disease Poster

Parkinson's Disease Poster

Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.